Fed. Circ. Affirms Invalidity Of AstraZeneca Inhaler Patent
The Federal Circuit on Thursday affirmed a lower court's ruling that invalidated AstraZeneca's patent on a pediatric asthma inhaler because of obviousness....To view the full article, register now.
Already a subscriber? Click here to view full article